Stocks
3065MBRG
YHDHealthcareBiotechnology
A clinical-stage biopharmaceutical company developing therapies for rare diseases, with a focus on metabolic and genetic disorders. Its pipeline includes investigational treatments targeting conditions with high unmet medical need, and investors track it for its potential to address niche markets with significant commercial upside.
Congressional Interest in 3065 (MBRG)
1 member of Congress has disclosed 1 trade in 3065 (MBRG), a Healthcare company. The buy/sell breakdown shows 1 purchase versus 0 sales, indicating net buying interest from lawmakers. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
1
Unique Politicians
1
Buys
1
Sells
0
Who in Congress Is Trading MBRG?
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2017-04-04 | Shelley M Capito | buy | $1K-$15K |